2nd China Pharma Due Diligence Conference 2022

Pre-Conference Training

14：00

Establishment and Responsibilities of Due

Dos and Don'ts for Cross-Border Due Diligence

15：30

Coffee Break

16：00

IP Due Diligence of Investment and Financing

Comparison of IP Requirements of Pharmaceutical Enterprises Listed   in

Hong Kong 18A,Science and Innovation Board and Nasdaq

18：00

Buffet Dinner

AGENDA OF April 1, 2022

08:40

Chairman Speech

08:50

New Thoughts and Methods of Optimizing R&D Pipeline by License-in from Overseas

09:25

Due Diligence on Intellectual Property InfringementRisk in the Field of Great Health

10:00

Interpretation of Listing Rules of Beijing Stock Exchange

10:35

Coffee Break

11:05

Remote Due Diligence under Epidemic Situation

11:40

Legal Risks Management of Pharmaceutical Overseas Investment

12:40

Buffet Lunch

14:00

Round-Table: Capital Involution、Incomp-lete Due Diligence and Blind Investment - How to Avoid and Investment Logic

14:55

Round-Table: How Venture Capital and Start-ups Grow Together?

15:50

Round-Table: Trends of Pharma/ Biotech Investment

16:45

Conference Closes

AGENDA OF March 31, 2022

07:30

Registration

09:00

Chairman Opening Speech

09:10

China Pharmaceutical & Biotech Industry Capital Market Review and Outlook

09:45

Round-Table: Strategies and Capabilities for Local Innovation Internationalization

10:40

Coffee Break

11:10

Global Wisdom & China Efficiency — on the Threshold of a New Era in Borderless Innovation

11:35

Round-Table: Cooperation Modes, Types and Preferences of Multinational Pharmaceutical Companies in China

12:30

Buffet Lunch

14:00

Status and Trends of Chinese Pharmaceutical Companies Going Overseas

14:35

License-out：Negotiation Strategies of Chinese Companies to MNC

15:10

Coffee Break

15:40

License-in: Search and Evaluation of BD Projects